Light-Scattering Spectroscopy for Detection of Breast Cancer
Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study
Sponsor: National Cancer Institute (NCI)
Terminated
Insufficient Accrual
Other terminated trials from National Cancer Institute (NCI)
Other Healthy, no Evidence of Disease trials with similar outcome
A NA clinical study on Healthy, no Evidence of Disease and Stage II Breast Cancer, this trial is terminated or withdrawn. The trial is conducted by National Cancer Institute (NCI) and has accumulated 9 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Dec 2021 [monthly]
Recruiting NA
-
Jul 2019 — Jan 2021 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jun 2018 — Jul 2019 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Nov 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- University of Southern California
For direct contact, visit the study record on ClinicalTrials.gov .